Immunic Inc. Stock
Price
Target price
€0.76
€0.76
-2.550%
-0.02
-2.550%
€6.90
16:51 / Tradegate
WKN: A2PHD4 / Symbol: IMUX / Name: Immunic / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Immunic Inc. Stock
A loss of -2.550% shows a downward development for Immunic Inc..
We see a rather positive sentiment for Immunic Inc. with 20 Buy predictions and 1 Sell predictions.
Based on the current price of 0.76 € the target price of 6 € shows a potential of 685.34% for Immunic Inc. which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Immunic Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Immunic Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
B****
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Immunic Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Immunic Inc. | -2.550% | -8.197% | -21.912% | -19.672% | 82.326% | -44.982% | -93.478% |
| NanoViricides Inc. | 0.930% | 16.062% | 34.132% | -0.885% | 20.430% | -6.667% | -67.723% |
| Ocuphire Pharma Inc. | -4.480% | -8.230% | 12.626% | 568.666% | 165.161% | -5.106% | - |
| Actinium Pharmaceuticals Inc. | -3.510% | 6.942% | 16.624% | -0.350% | -5.551% | -86.509% | -82.462% |
Comments
Immunic (IMUX) was downgraded by Wall Street Zen from "hold" to "sell".
Show more
Ratings data for IMUX provided by MarketBeat
Immunic (IMUX) had its price target lowered by HC Wainwright from $8.00 to $5.00. They now have a "buy" rating on the stock.
Show more
Ratings data for IMUX provided by MarketBeat
Immunic (NASDAQ:IMUX) had its price target lowered by analysts at D. Boral Capital from $8.00 to $4.00. They now have a "buy" rating on the stock.
Show more
Ratings data for IMUX provided by MarketBeat
News
EQS-News: Immunic, Inc. Announces 1-for-10 Reverse Stock Split
EQS-News: Immunic, Inc. Announces 1-for-10 Reverse Stock Split
EQS-News: Immunic to Participate in Scientific and Medical Conferences in April
EQS-News: Immunic to Participate in Scientific and Medical Conferences in April
EQS-News: Immunic Regains Compliance with Nasdaq Minimum Bid Price Requirement
EQS-News: Immunic Regains Compliance with Nasdaq Minimum Bid Price Requirement